Research Tree Research Tree Logo

  • Try our Investor Tool
  • Login
  • Sign Up

Research Tree Logo

  • Login
  • Sign Up
  • Features
  • Pricing
  • Reg.News
  • Contact
  • Try our Investor Tool
  • Login
  • Sign Up
  • Providers
  • Companies
⨯
LIVE

Event in Progress:

Join Here ×
  • Providers
  • Companies
⨯
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest
  • Contact
Research >
THE MONTHLY July 2019

working
  • 02 Jul 2019

THE MONTHLY July 2019


Advanced Oncotherapy Plc (AVO:LON), 22.0 | AJ Bell Plc (AJB:LON), 269 | Allergy Therapeutics plc (AGY:LON), 21.0 | Arbuthnot Banking Group PLC (ARBB:LON), 855 | City of London Investment Group PLC (CLIG:LON), 422 | Diurnal Group plc (DNL:LON), 11.0 | DP Poland PLC (DPP:LON), 6.0 | Gateley (Holdings) Plc (GTLY:LON), 200 | Koovs (KOOV:LON), 0 | Lightwaverf (LWRF:LON), 0 | Morses Club Plc (MCL:LON), 8.0 | Murgitroyd Group (MUR:LON), 0 | Non-Standard Finance Plc (NSF:LON), 2.0 | Oxford BioMedica plc (OXB:LON), 451 | Palace Capital plc (PCA:LON), 267 | Primary Health Properties PLC (PHP:LON), 137 | R.E.A. Holdings plc (RE:LON), 130 | Redx Pharma Plc (REDX:LON), 67.0 | RM Infrastructure Income PLC GBP (RMII:LON), 91.0 | Shield Therapeutics Plc (STX:LON), 7.0 | 600 Group PLC (SIXH:LON), 14.0 | Tissue Regenix Group plc (TRX:LON), 0 | Titon Holdings Plc (TON:LON), 86.0 | Urban Logistics REIT plc (SHED:LON), 161 | Volta Finance Limited (VTA:LON), 560 | Warpaint London PLC (W7L:LON), 134 | ValiRx PLC (VAL:LON), 11.0

  • Hardman & Co
    • Brian Moretta

    • 37 pages

Stock Image



 
Stock Image



When advisers first start looking at business relief (BR) products, there is much to take in: the rules governing such products; the investment strategies being used; and what the investment risk is. It is easy to lose sight of the fact that, for non-AIM products, the investment is being made directly into a company or partnership, rather than a fund. It is, therefore, essential that governance is part of the diligence process.


Sign up for free to access

Get access to the latest equity research in real-time from 12 commissioned providers.

Get access to the latest equity research in real-time from 12 commissioned providers.


Get Started
Already a member? Log in here

THE MONTHLY July 2019


Advanced Oncotherapy Plc (AVO:LON), 22.0 | AJ Bell Plc (AJB:LON), 269 | Allergy Therapeutics plc (AGY:LON), 21.0 | Arbuthnot Banking Group PLC (ARBB:LON), 855 | City of London Investment Group PLC (CLIG:LON), 422 | Diurnal Group plc (DNL:LON), 11.0 | DP Poland PLC (DPP:LON), 6.0 | Gateley (Holdings) Plc (GTLY:LON), 200 | Koovs (KOOV:LON), 0 | Lightwaverf (LWRF:LON), 0 | Morses Club Plc (MCL:LON), 8.0 | Murgitroyd Group (MUR:LON), 0 | Non-Standard Finance Plc (NSF:LON), 2.0 | Oxford BioMedica plc (OXB:LON), 451 | Palace Capital plc (PCA:LON), 267 | Primary Health Properties PLC (PHP:LON), 137 | R.E.A. Holdings plc (RE:LON), 130 | Redx Pharma Plc (REDX:LON), 67.0 | RM Infrastructure Income PLC GBP (RMII:LON), 91.0 | Shield Therapeutics Plc (STX:LON), 7.0 | 600 Group PLC (SIXH:LON), 14.0 | Tissue Regenix Group plc (TRX:LON), 0 | Titon Holdings Plc (TON:LON), 86.0 | Urban Logistics REIT plc (SHED:LON), 161 | Volta Finance Limited (VTA:LON), 560 | Warpaint London PLC (W7L:LON), 134 | ValiRx PLC (VAL:LON), 11.0

  • Published: 02 Jul 2019
  • Author: Brian Moretta
  • Pages: 37
  • Hardman & Co


When advisers first start looking at business relief (BR) products, there is much to take in: the rules governing such products; the investment strategies being used; and what the investment risk is. It is easy to lose sight of the fact that, for non-AIM products, the investment is being made directly into a company or partnership, rather than a fund. It is, therefore, essential that governance is part of the diligence process.



More Content

More Content

Cenkos: ValiRx Plc -- Progressing the Preclinical Pipeline

Companies: ValiRx PLC

Cenkos Securities

ValiRx - Update on proposed sub-license of VAL201

Companies: ValiRx PLC

BRR Media

SP Angel Healthcare Conditions- 30-06-2022

Companies: Shield Therapeutics Plc

SP Angel

ValiRx - VAL401 Update

Companies: ValiRx PLC

BRR Media

Shield Therapeutics - FY results: focus on funding and growing the US

Companies: Shield Therapeutics Plc

finnCap

Useful Links

  • Features
  • Pricing
  • RNS/Newswires Feeds
  • Providers Hub
  • Company Hub

Account

  • Login
  • Free Trial - Join Now
  • Contact
Follow us on Linkedin Follow us on Twitter

Share:

Copyright © 2022 Research Tree | All Rights Reserved. | Terms of Service and Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Top
  • Home
  • Features
  • Pricing
  • Event Hub
  • Reg.News
  • Short Interest Tracker
  • Blogs
    • Academy
    • Insights
    • News
    • Research Tree
    • The Naked Fund Manager
  • Ideas & Picks
    • Ideas Hub
    • Stock Pick League
    • Themes & Screens Hub
  • Explore Content
    • Regions
      • UK
      • Rest of EMEA
      • N America
      • APAC
      • LatAm
    • Exchanges
      • Aquis Apex
      • Australian Securities Exchange
      • Canadian Securities Exchange
      • Euronext Paris
      • London Stock Exchange (domestic)
      • SIX Swiss Exchange
    • Sectors
      • Automobile Industry
      • Banks
      • Building & Construction
      • Chemicals
      • Discretionary Personal Goods
      • Discretionary Retail
      • Energy
      • Financial Services
      • Food & Drink
      • Food Production
      • Health
      • Household Goods & DIY
      • Industrial Equipment, Goods & Services
      • Insurance & Reinsurance
      • Leisure, Tourism & Travel
      • Media
      • Other
      • Real Estate
      • Resources
      • Staple Retail
      • Technology
      • Telecoms
      • Trusts, ETFs & Funds
      • Utilities
    • Small / Large Cap
      • UK100
      • UK250
      • UK Smallcap
      • UK Other Main Markets
      • Other
    • Private/EIS
      • EIS Single Company
      • EIS/SEIS Funds
      • IHT Products
      • SEIS Single Company
      • VCT Funds
  • Providers
    • Free/Commissioned
      • Align Research
      • BNP Paribas Exane - Sponsored Research
      • BRR Media
      • Calvine Partners
      • Capital Access Group
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Edison
      • Equity Development
      • eResearch
      • Fidante Partners
      • Five Minute Pitch TV
      • goetzpartners securities Limited
      • Hardman & Co
      • Inbound Capital
      • Independent Investment Research
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Magnitogorsk Iron and steel works
      • Mello Events
      • piworld.co.uk
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • RaaS - Research as a Service
      • Radnor Capital Partners
      • Research Tree
      • SEAL Advisors Ltd
      • ShareSoc
      • Trinity Delta
      • Yellowstone Advisory
    • High Net Worth Offering
      • Fox-Davies Capital
      • Allenby Capital
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane - Sponsored Research
      • Canaccord Genuity
      • Cenkos Securities
      • Couloir Capital
      • Dowgate Capital
      • finnCap
      • First Berlin
      • First Sentinel
      • Hannam & Partners
      • Hybridan
      • Liberum
      • Longspur Research
      • Louis Capital
      • Magnitogorsk Iron and steel works
      • Medley Global Advisors
      • Northland Capital Partners
      • QuotedData Professional
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • The Life Sciences Division
      • VSA Capital
      • WHIreland
      • Whitman Howard
      • Yellowstone Advisory
      • Zeus Capital
    • Institutional Offering
      • Fox-Davies Capital
      • Align Research
      • Allenby Capital
      • AlphaValue
      • Alternative Resource Capital
      • Arctic Securities
      • Arden Partners
      • Auctus Advisors
      • Baptista Research
      • BNP Paribas Exane
      • BNP Paribas Exane - Sponsored Research
      • BRR Media
      • Bryan, Garnier & Co
      • Calderwood Capital
      • Calvine Partners
      • Canaccord Genuity
      • Capital Access Group
      • Cenkos Securities
      • Checkpoint Partners
      • Clear Capital Markets
      • Couloir Capital
      • Dowgate Capital
      • Edison
      • Equity Development
      • eResearch
      • Fidante Partners
      • finnCap
      • First Berlin
      • First Sentinel
      • Five Minute Pitch TV
      • goetzpartners securities Limited
      • Hannam & Partners
      • Hardman & Co
      • Hybridan
      • Inbound Capital
      • Independent Investment Research
      • InterAxS Global
      • Kepler | Absolute Hedge
      • Kepler | Trust Intelligence
      • Liberum
      • London Stock Exchange
      • Longspur Research
      • Magnitogorsk Iron and steel works
      • Mello Events
      • Northland Capital Partners
      • Numis
      • Panmure Gordon
      • Peel Hunt
      • piworld.co.uk
      • Proactive
      • Progressive Equity Research
      • Quantum Research Group
      • QuotedData
      • RaaS - Research as a Service
      • Radnor Capital Partners
      • Research Tree
      • SEAL Advisors Ltd
      • Shard Capital
      • ShareSoc
      • Shore Capital
      • SI Capital
      • Singer Capital Markets
      • SP Angel
      • Stanford Capital Partners
      • Stifel
      • Stifel FirstEnergy
      • Stockdale Securities
      • Tamesis Partners
      • The Life Sciences Division
      • Trinity Delta
      • VSA Capital
      • WHIreland
      • Whitman Howard
      • Yellowstone Advisory
      • Zeus Capital
    • Video/Audio Interviews
      • BRR Media
      • Capital Access Group
      • Couloir Capital
      • Edison
      • Equity Development
      • Five Minute Pitch TV
      • piworld.co.uk
      • Proactive
      • QuotedData
      • RaaS - Research as a Service
      • Research Tree
      • Yellowstone Advisory
    • Event Providers
      • Capital Access Group
      • Cenkos Securities
      • Couloir Capital
      • Edison
      • Equity Development
      • Hardman & Co
      • InterAxS Global
      • Kepler | Trust Intelligence
      • London Stock Exchange
      • Mello Events
      • piworld.co.uk
      • QuotedData
      • Research Tree
      • ShareSoc
      • VSA Capital
      • Yellowstone Advisory
  • Contact
  • Sign Up
  • Sign In